Published in Dialogues Clin Neurosci on June 01, 2003
Effectiveness of sertraline in treatment of depression in a consecutive sample of patients with acute myocardial infarction: six month prospective study on outcome. Clin Pract Epidemiol Ment Health (2005) 0.82
Role of peripheral vascular resistance for the association between major depression and cardiovascular disease. J Cardiovasc Pharmacol (2015) 0.75
Socioeconomic status and health. The challenge of the gradient. Am Psychol (1994) 13.59
Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol (1987) 9.10
Depression following myocardial infarction. Impact on 6-month survival. JAMA (1993) 8.64
Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA (2002) 8.28
The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry (1994) 7.36
Depression and 18-month prognosis after myocardial infarction. Circulation (1995) 7.22
MRI-defined vascular depression. Am J Psychiatry (1997) 2.92
Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation (1996) 2.88
Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med (2000) 2.86
Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology (1993) 2.79
Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med (1999) 2.39
Post-infarction depression and incomplete recovery 6 months after acute myocardial infarction. Lancet (1994) 2.39
Effects of mental stress on myocardial ischemia during daily life. JAMA (1997) 2.30
Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation (1996) 2.27
The nature and course of depression following myocardial infarction. Arch Intern Med (1989) 2.19
Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med (1998) 2.07
Nicotine and carbon monoxide content of cigarette smoke and the risk of myocardial infarction in young men. N Engl J Med (1983) 1.80
Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol (1995) 1.73
Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly). Arch Intern Med (1996) 1.72
Major depressive disorder in coronary artery disease. Am J Cardiol (1987) 1.69
Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis (1989) 1.69
Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol (1995) 1.68
Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med (1989) 1.65
Platelet activation in depression and effects of sertraline treatment: An open-label study. Am J Psychiatry (2000) 1.65
Extracardiac contributions to chest pain perception in patients 6 months after acute myocardial infarction. Am Heart J (1999) 1.50
Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiatry (1994) 1.45
Excess fatigue as a precursor of myocardial infarction. Eur Heart J (1988) 1.41
Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch Gen Psychiatry (1976) 1.40
Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA (1998) 1.38
Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosom Med (1982) 1.36
Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol (1990) 1.35
Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry (1997) 1.34
Heart rate variability in patients with coronary artery disease: differences in patients with higher and lower depression scores. Psychosom Med (1997) 1.26
Depression and cardiovascular diseases. Acta Psychiatr Scand Suppl (1994) 1.23
Medial orbital frontal lesions in late-onset depression. Biol Psychiatry (2001) 1.20
Depression and risk of coronary heart disease in elderly men and women: New Haven EPESE, 1982-1991. Established Populations for the Epidemiologic Studies of the Elderly. Arch Intern Med (1998) 1.17
Depression in patients with coronary heart disease. A 12-month follow-up. Gen Hosp Psychiatry (1996) 1.16
Life adjustment postmyocardial infarction: determining predictive variables. Arch Intern Med (1977) 1.13
Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch Gen Psychiatry (2000) 1.12
Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. N Engl J Med (1982) 1.10
Mental health status as a predictor of morbidity and mortality: a 15-year follow-up of members of a health maintenance organization. Am J Public Health (1994) 1.09
Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J Clin Psychopharmacol (2000) 1.09
Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. Am Heart J (1999) 1.06
Depression in patients with coronary artery disease. Depression (1996) 1.05
Depression and heart disease: evidence of a link, and its therapeutic implications. CNS Drugs (2002) 1.05
Psychosocial factors and risk of ischaemic heart disease and death in women: a twelve-year follow-up of participants in the population study of women in Gothenburg, Sweden. J Psychosom Res (1986) 1.02
Distress or illness? A study of psychological symptoms after myocardial infarction. Br J Psychiatry (1983) 1.00
Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder. J Clin Psychopharmacol (1997) 0.99
Performance feedback deficit in geriatric depression. Biol Psychiatry (2001) 0.98
Ability of heart rate variability to predict prognosis in patients with advanced congestive heart failure. Am J Cardiol (1997) 0.97
Depressed mood and subsequent physical illness. Am J Psychiatry (1979) 0.91
Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease. Am J Psychiatry (1999) 0.88
Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine. Clin Pharmacol Ther (1999) 0.84
Cardiovascular complications of antidepressant therapy. Interactions at the adrenergic neuron. Am Heart J (1972) 0.84
Personality factors differentially predict exercise behavior in men and women. Womens Health (1997) 0.83
Psychological aspects of myocardial infarction. Med Clin North Am (1977) 0.83
Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure. J Clin Psychopharmacol (1987) 0.81
Platelet activation and inhibition in unstable coronary syndromes. Am J Cardiol (1997) 0.80
Treatment of depression following acute myocardial infarction. JAMA (2002) 0.79
Depression in coronary heart disease. What is the appropriate diagnostic threshold? Psychosomatics (1999) 0.76